NASDAQ: ENTAEnanta Pharmaceuticals Inc Stock Ownership - Who owns Enanta Pharmaceuticals?
Insider buying vs selling
Have Enanta Pharmaceuticals Inc insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Scott T. Rottinghaus | Med | 2026-08-08 | 1,467 | $13.34 | $19.57kSell |
| Scott T. Rottinghaus | Chief Medical Officer | 2026-02-12 | 3,413 | $14.25 | $48.64kSell |
| Jay R. Luly | President and CEO | 2026-02-12 | 6,155 | $14.25 | $87.71kSell |
| Yat Sun Or | Chief Scientific Officer | 2026-02-12 | 3,413 | $14.25 | $48.64kSell |
| Tara Lynn Kieffer | Chief Product Strategy Officer | 2026-02-12 | 3,257 | $14.25 | $46.41kSell |
| Matthew Paul Kowalsky | Chief Legal Officer | 2026-02-12 | 1,902 | $14.25 | $27.10kSell |
| Brendan Luu | Chief Business Officer | 2026-02-12 | 3,257 | $14.25 | $46.41kSell |
| Harry R. Trout Iii | Vice President Finance Principal Financial Officer | 2025-12-05 | 542 | $14.23 | $7.71kSell |
| Kathleen S. Capps | Executive Director of Accounting Controller Principal Accounting Officer | 2025-12-05 | 323 | $14.23 | $4.60kSell |
| Tara Lynn Kieffer | Chief Product Strategy Officer | 2025-12-05 | 2,106 | $14.23 | $29.97kSell |
ENTA insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when ENTA insiders and whales buy or sell their stock.
ENTA Shareholders
What type of owners hold Enanta Pharmaceuticals Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Helmut Schuhsler | 19.78% | 5,761,609 | $72.02M | Insider |
| Saints Capital Granite LP | 12.01% | 3,497,683 | $43.72M | Insider |
| Shionogi Co Ltd | 5.49% | 1,599,760 | $20.00M | Insider |
| Tvm V Life Science Ventures Gmbh Co Kg | 3.93% | 1,144,932 | $14.31M | Insider |
| Jay R. Luly | 2.99% | 871,871 | $10.90M | Insider |
| Marc E. Goldberg | 1.88% | 547,606 | $6.85M | Insider |
| Yat Sun Or | 1.29% | 374,854 | $4.69M | Insider |
| Nathaniel S. Gardiner | 0.44% | 128,259 | $1.60M | Insider |
| Paul J. Mellett | 0.33% | 95,884 | $1.20M | Insider |
| Brendan Luu | 0.14% | 41,634 | $520.43k | Insider |
ENTA vs Biotech Stocks
Enanta Pharmaceuticals Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.